Literature DB >> 21540993

Is tau a suitable therapeutical target in tauopathies?

Elena Gomez de Barreda1, Jesús Avila.   

Abstract

Tau is an intracellular protein, found mainly in neurons, but it can also be found in the extracellular space in pathological situations. Here we discuss whether intracellular tau, in aggregated form or modified by phosphorylation, could be toxic inside a neuron. On the other hand, it has been proposed that extracellular tau could be toxic. In this review, we address the question if the elimination of tau would be a possible therapeutic method to avoid tauopathy disorder and we suggest ways to eliminate intracellular and extracellular tau as treatment.

Entities:  

Keywords:  Alzheimer disease; Phosphorylation; Tau; Tauopathy; Therapy

Year:  2010        PMID: 21540993      PMCID: PMC3083962          DOI: 10.4331/wjbc.v1.i5.81

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  61 in total

1.  14-3-3zeta is an effector of tau protein phosphorylation.

Authors:  M Hashiguchi; K Sobue; H K Paudel
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease.

Authors:  C X Gong; T Lidsky; J Wegiel; L Zuck; I Grundke-Iqbal; K Iqbal
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

3.  Tubulin, actin, and tau protein interactions and the study of their macromolecular assemblies.

Authors:  Gustavo A Farias; Juan P Muñoz; Jorge Garrido; Ricardo B Maccioni
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

4.  Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.

Authors:  X Z Zhou; O Kops; A Werner; P J Lu; M Shen; G Stoller; G Küllertz; M Stark; G Fischer; K P Lu
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

5.  A protein factor essential for microtubule assembly.

Authors:  M D Weingarten; A H Lockwood; S Y Hwo; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

6.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.

Authors:  P J Lu; G Wulf; X Z Zhou; P Davies; K P Lu
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

7.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin.

Authors:  D W Cleveland; S Y Hwo; M W Kirschner
Journal:  J Mol Biol       Date:  1977-10-25       Impact factor: 5.469

Review 8.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.

Authors:  J J Lucas; F Hernández; P Gómez-Ramos; M A Morán; R Hen; J Avila
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

10.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

Authors:  H N Dawson; A Ferreira; M V Eyster; N Ghoshal; L I Binder; M P Vitek
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  2 in total

1.  An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide.

Authors:  Silvia Bolognin; Julie Blanchard; Xiaochuan Wang; Gustavo Basurto-Islas; Yunn Chyn Tung; Erik Kohlbrenner; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Acta Neuropathol       Date:  2011-11-15       Impact factor: 17.088

2.  The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.

Authors:  Cheng Li; Weizhen Liu; Xiaohui Li; Zijuan Zhang; Huaxin Qi; Shijin Liu; Ningning Yan; Ying Xing; Christian Hölscher; Zhiju Wang
Journal:  Brain Behav       Date:  2020-01-20       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.